At the time of writing, Salarius Pharmaceuticals Inc [SLRX] stock is trading at $0.93, up 4.79%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SLRX shares have gain 17.73% over the last week, with a monthly amount drifted -75.17%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Salarius Pharmaceuticals Inc [NASDAQ: SLRX] stock has seen the most recent analyst activity on April 27, 2020, when Ladenburg Thalmann initiated its Buy rating and assigned the stock a price target of $3.80.
For the past year, the stock price of Salarius Pharmaceuticals Inc fluctuated between $0.71 and $108.00. Salarius Pharmaceuticals Inc [NASDAQ: SLRX] shares were valued at $0.93 at the most recent close of the market.
Analyzing the SLRX fundamentals
Gross Profit Margin for this corporation currently stands at 0.0% with Operating Profit Margin at -1138.43%, Pretax Profit Margin comes in at -1130.76%, and Net Profit Margin reading is -1130.76%. To continue investigating profitability, this company’s Return on Assets is posted at -0.82, Equity is -4.01 and Total Capital is -1.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.8850 points at the first support level, and at 0.8450 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.9450, and for the 2nd resistance point, it is at 0.9650.
Ratios To Look Out For
It is important to note that Salarius Pharmaceuticals Inc [NASDAQ:SLRX] has a current ratio of 2.79. In addition, the Quick Ratio stands at 2.79 and the Cash Ratio stands at 4.36.
Transactions by insiders
Recent insider trading involved HANISH ARNOLD C, Director, that happened on Nov 20 ’25 when 5000.0 shares were purchased. Exec VP Finance, CFO, Rosenblum Mark J completed a deal on Nov 20 ’25 to buy 20000.0 shares.
